Filing Details
- Accession Number:
- 0001209191-19-050363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-20 17:18:28
- Reporting Period:
- 2019-07-25
- Accepted Time:
- 2019-09-20 17:18:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-25 | 65 | $5.87 | 161,752 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-26 | 65 | $5.86 | 161,817 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-29 | 65 | $5.87 | 161,882 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-30 | 65 | $5.83 | 161,947 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-31 | 65 | $5.94 | 162,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-02 | 130 | $6.15 | 162,142 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-05 | 65 | $6.17 | 162,207 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-07 | 65 | $6.07 | 162,272 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-09 | 130 | $6.02 | 162,402 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-12 | 65 | $5.91 | 162,467 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-13 | 65 | $5.78 | 162,532 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-14 | 65 | $5.49 | 162,597 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-16 | 130 | $5.62 | 162,727 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-19 | 65 | $5.51 | 162,792 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 65 | $5.43 | 162,857 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-21 | 65 | $5.49 | 162,922 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-22 | 65 | $5.31 | 162,987 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-23 | 65 | $5.38 | 163,052 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-27 | 130 | $5.19 | 163,182 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-29 | 130 | $5.04 | 163,312 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-30 | 65 | $5.14 | 163,377 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-04 | 65 | $4.79 | 163,442 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-06 | 130 | $4.91 | 163,572 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-09 | 65 | $5.19 | 163,637 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-10 | 65 | $5.38 | 163,702 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-11 | 65 | $5.02 | 163,767 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-13 | 130 | $5.18 | 163,897 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-16 | 65 | $4.97 | 163,962 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-18 | 130 | $4.93 | 164,092 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-09-19 | 65 | $5.21 | 164,157 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.